Data highlights from the ACHIEVE-1 Phase III trial for Eli Lilly's GLP-1 At 40 weeks, Eli Lilly's orforglipron enabled a superior reduction in A1C compared to placebo
This peptide plays a critical role in tissue regeneration, inflammation modulation, and cellular migration
Last Published 12.01.2025 Effective Date: 12.01.2025 This policy addresses the use of Benlysta (belimumab) injection for intravenous infusion for the treatment of systemic lupus erythematosus (SLE) and active lupus nephritis (LN)
This meta-analysis showed that there was a dose dependent decreased risk of NAFLD occurrence that became statistically significant at three cups of coffee per day
Combining Sermorelin with Semaglutide: Protocol Considerations Key Takeaways Combining sermorelin with semaglutide targets two distinct metabolic pathwaysGLP-1 receptor agonism for appetite suppression and GHRH-mediated growth hormone release for fat oxidation and lean tissue preservation
Reducing visceral fat is key to improving overall health, and Wegovy, a weight loss injection, has shown promising results in this area